← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #442 OF 1,000 MOST-CITED

HACCP plan - food hazards not listed

FDA cited this observation 43 times across 40 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods43
BY FISCAL YEAR
FY20261
FY20257
FY20245
FY20232
FY20223
FY20211
FY20203
FY20197
FY201810
FY20174

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 3.6× the rate of the average FDA-cited firm (30.0% vs 8.3%), across 40 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your Professional access…

How FDA worded it — real examples

Your HACCP plan does not list all food hazards that are reasonably likely to occur.

Tepetepeque Limited Liability Company · Dallas, Texas · Foods · 2026-06-10

Your HACCP plan does not list all food hazards that are reasonably likely to occur.

Everpress Juice, Inc. · Philadelphia, Pennsylvania · Foods · 2025-07-24

Your HACCP plan does not list all food hazards that are reasonably likely to occur.

Atelier Patrick Font S.A.S · Chabaniere · Foods · 2025-06-26

Your HACCP plan does not list all food hazards that are reasonably likely to occur.

McCutcheon's Apple Products, Inc. · Frederick, Maryland · Foods · 2025-03-28

Your HACCP plan does not list all food hazards that are reasonably likely to occur.

LYU YUAN PASTURE CO LTD · Tainan City · Foods · 2025-03-19

Your HACCP plan does not list all food hazards that are reasonably likely to occur.

Pulpas y Procesados Del Agro S.A. · Sullana · Foods · 2025-01-14

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

HACCPFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →